Robert J. Gould
Insider
IndividualSelling only2 10b5-1 trades
- 2025
- Jul 2, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert J. Gould files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $1.49M in FULC purchases and sales in the last 12 months
- Alan Ezekowitz - $66K in FULC purchases and sales in the last 12 months
- Curtis Gale Oltmans - $45K in FULC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert J. Gould?
Robert J. Gould is a corporate insider of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robert J. Gould last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 4 filings going back to 2025.
Has Robert J. Gould been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($507K) across all tracked filings.
